» Articles » PMID: 25182020

Nutrition, the Brain and Cognitive Decline: Insights from Epigenetics

Overview
Journal Eur J Clin Nutr
Date 2014 Sep 4
PMID 25182020
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Nutrition affects the brain throughout life, with profound implications for cognitive decline and dementia. These effects are mediated by changes in expression of multiple genes, and responses to nutrition are in turn affected by individual genetic variability. An important layer of regulation is provided by the epigenome: nutrition is one of the many epigenetic regulators that modify gene expression without changes in DNA sequence. Epigenetic mechanisms are central to brain development, structure and function, and include DNA methylation, histone modifications and non-protein-coding RNAs. They enable cell-specific and age-related gene expression. Although epigenetic events can be highly stable, they can also be reversible, highlighting a critical role for nutrition in prevention and treatment of disease. Moreover, they suggest key mechanisms by which nutrition is involved in the pathogenesis of age-related cognitive decline: many nutrients, foods and diets have both immediate and long-term effects on the epigenome, including energy status, that is, energy intake, physical activity, energy metabolism and related changes in body composition, and micronutrients involved in DNA methylation, for example, folate, vitamins B6 and B12, choline, methionine. Optimal brain function results from highly complex interactions between numerous genetic and environmental factors, including food intake, physical activity, age and stress. Future studies linking nutrition with advances in neuroscience, genomics and epigenomics should provide novel approaches to the prevention of cognitive decline, and treatment of dementia and Alzheimer's disease.

Citing Articles

Epigenetics as a link between environmental factors and dementia risk.

Koulouri A, Zannas A J Alzheimers Dis Rep. 2025; 8(1):1372-1380.

PMID: 40034348 PMC: 11863733. DOI: 10.1177/25424823241284227.


A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study.

Pereira A, de Souza C, Alvarez-Cordoba M, Reche-Lopez D, Sanchez-Alcazar J Orphanet J Rare Dis. 2024; 19(1):442.

PMID: 39609877 PMC: 11606047. DOI: 10.1186/s13023-024-03453-x.


The Hidden Dangers of Sedentary Living: Insights into Molecular, Cellular, and Systemic Mechanisms.

Guerreiro Diniz D, Bento-Torres J, da Costa V, Carvalho J, Tomas A, Galdino de Oliveira T Int J Mol Sci. 2024; 25(19).

PMID: 39409085 PMC: 11476792. DOI: 10.3390/ijms251910757.


Joint Exposure to Multiple Air Pollutants, Genetic Susceptibility, and Incident Dementia: A Prospective Analysis in the UK Biobank Cohort.

Zhang S, Cao H, Chen K, Gao T, Zhao H, Zheng C Int J Public Health. 2024; 69:1606868.

PMID: 38426188 PMC: 10901982. DOI: 10.3389/ijph.2024.1606868.


Cognitive decline monitoring through a web-based application.

Sanchez-Vincitore L, Cubilla-Bonnetier D, Marte-Santana H, Dunabeitia J Front Aging Neurosci. 2023; 15:1212496.

PMID: 37869371 PMC: 10585037. DOI: 10.3389/fnagi.2023.1212496.


References
1.
Qureshi I, Mehler M . Understanding neurological disease mechanisms in the era of epigenetics. JAMA Neurol. 2013; 70(6):703-10. PMC: 4465100. DOI: 10.1001/jamaneurol.2013.1443. View

2.
Issa J . Aging and epigenetic drift: a vicious cycle. J Clin Invest. 2014; 124(1):24-9. PMC: 3871228. DOI: 10.1172/JCI69735. View

3.
Livesey F . Stem cell models of Alzheimer's disease and related neurological disorders. Alzheimers Res Ther. 2012; 4(6):44. PMC: 3580453. DOI: 10.1186/alzrt147. View

4.
Sable P, Kale A, Joshi S . Prenatal omega 3 fatty acid supplementation to a micronutrient imbalanced diet protects brain neurotrophins in both the cortex and hippocampus in the adult rat offspring. Metabolism. 2013; 62(11):1607-22. DOI: 10.1016/j.metabol.2013.06.002. View

5.
Chouliaras L, Mastroeni D, Delvaux E, Grover A, Kenis G, Hof P . Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients. Neurobiol Aging. 2013; 34(9):2091-9. PMC: 3955118. DOI: 10.1016/j.neurobiolaging.2013.02.021. View